Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice

被引:79
作者
Jiang, Chuancang
Foley, Julie
Clayton, Natasha
Kissling, Grace
Jokinen, Micheal
Herbert, Ronald
Diaz, Marilyn
机构
[1] NIEHS, Genet Mol Lab, NIH, Res Triangle Pk, NC 27709 USA
[2] NIEHS, Lab Expt Pathol, NIH, Res Triangle Pk, NC 27709 USA
[3] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA
[4] Chalk River Labs, Pathol Associates, Cary, NC 27513 USA
关键词
D O I
10.4049/jimmunol.178.11.7422
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We generated MRL/Ipr mice deficient in activation-induced deaminase (AID). Because AID is required for Ig hypermutation and class switch recombination, these mice lack hypermutated IgG Abs. Unlike their AID wild-type littermates, AID-deficient MRL/Ipr mice not only lacked autoreactive IgG Abs but also experienced a dramatic increase in the levels of autoreactive IgM. This phenotype in AID-deficient mice translated into a significant reduction in glomerulonephritis, minimal mononuclear cell infiltration in the kidney, and a dramatic increase in survival to levels comparable to those previously reported for MRL/Ipr mice completely lacking B cells and well below those of mice lacking secreted Abs. Therefore, this study wherein littermates with either high levels of autoreactive IgM or autoreactive IgG were directly examined proves that autoreactive IgM Abs alone are not sufficient to promote kidney disease in MRL/Ipr mice. In addition, the substantial decrease in mortality combined with a dramatic increase in autoreactive IgM Abs in AID-deficient MRL/Ipr mice suggest that autoreactive IgM Abs might not only fail to promote nephritis but may also provide a protective role in MRL/Ipr mice. This novel mouse model containing high levels of autoreactive, unmutated IgM Abs will help delineate the contribution of autoreactive IgM to autoimmunity.
引用
收藏
页码:7422 / 7431
页数:10
相关论文
共 75 条
[1]   SPONTANEOUS MURINE LUPUS-LIKE SYNDROMES - CLINICAL AND IMMUNOPATHOLOGICAL MANIFESTATIONS IN SEVERAL STRAINS [J].
ANDREWS, BS ;
EISENBERG, RA ;
THEOFILOPOULOS, AN ;
IZUI, S ;
WILSON, CB ;
MCCONAHEY, PJ ;
MURPHY, ED ;
ROTHS, JB ;
DIXON, FJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (05) :1198-1215
[2]   Signaling through up-regulated C3a receptor is key to the development of experimental lupus nephritis [J].
Bao, LH ;
Osawe, I ;
Haas, M ;
Quigg, RJ .
JOURNAL OF IMMUNOLOGY, 2005, 175 (03) :1947-1955
[3]   Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice [J].
Bao, LH ;
Haas, M ;
Boackle, SA ;
Kraus, DM ;
Cunningham, PN ;
Park, P ;
Alexander, JJ ;
Anderson, RK ;
Culhane, K ;
Holers, VM ;
Quigg, RJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (07) :3601-3607
[4]   MATURATION OF THE IMMUNE-RESPONSE IN GERMINAL-CENTERS [J].
BEREK, C ;
BERGER, A ;
APEL, M .
CELL, 1991, 67 (06) :1121-1129
[5]   Natural antibodies and the autoimmunity of atherosclerosis [J].
Binder, CJ ;
Silverman, GJ .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2005, 26 (04) :385-404
[6]   Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM [J].
Boes, M ;
Schmidt, T ;
Linkemann, K ;
Beaudette, BC ;
Marshak-Rothstein, A ;
Chen, JZ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (03) :1184-1189
[7]   Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies [J].
Botto, M ;
Dell'Agnola, C ;
Bygrave, AE ;
Thompson, EM ;
Cook, HT ;
Petry, F ;
Loos, M ;
Pandolfi, PP ;
Walport, MJ .
NATURE GENETICS, 1998, 19 (01) :56-59
[8]   Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice [J].
Brard, F ;
Shannon, M ;
Prak, EL ;
Litwin, S ;
Weigert, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (05) :691-704
[9]  
Chan O, 1998, J IMMUNOL, V160, P51
[10]  
Chan OTM, 1999, J IMMUNOL, V163, P3592